Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMA7OEF)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Extracellular lysophospholipase D (E-NPP2)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Cudetaxestat	DMYLDN9	Idiopathic pulmonary fibrosis	CB03.4	Phase 2	[2]
PMID28447479-Compound-24	DMDOVIZ	N. A.	N. A.	Patented	[1]
Tetra-hydro-carboline derivative 2	DMXTL7V	N. A.	N. A.	Patented	[1]
PMID28447479-Compound-14	DMA91X2	N. A.	N. A.	Patented	[1]
Pyrimidinone derivative 5	DMLFY57	N. A.	N. A.	Patented	[1]
Heteroaromatic ring derivative 3	DMKJL5T	N. A.	N. A.	Patented	[1]
Pyrazolo[3,4-c]pyridine derivative 1	DMQHCDZ	N. A.	N. A.	Patented	[1]
Pyrazole derivative 87	DMGZUAY	N. A.	N. A.	Patented	[1]
Pyridine and pyrimidine derivative 1	DMGEYJW	Fibrosis	GA14-GC01	Patented	[1]
Imidazopyrimidinone derivative 1	DMWN17V	N. A.	N. A.	Patented	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Extracellular lysophospholipase D (E-NPP2)	TTSCIM2	ENPP2_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Autotaxin inhibitors: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):815-829.
2	An updated patent review of autotaxin inhibitors (2017-present). Expert Opin Ther Pat. 2021 May;31(5):421-434.